Rempp Hansjörg, Loh Henning, Hoffmann Rüdiger, Rothgang Eva, Pan Li, Claussen Claus D, Clasen Stephan
Eberhard Karls University of Tübingen, Department of Diagnostic and Interventional Radiology, Tübingen, Germany.
J Magn Reson Imaging. 2014 Aug;40(2):432-9. doi: 10.1002/jmri.24371. Epub 2013 Oct 29.
To retrospectively evaluate the conspicuity of liver lesions in a fluoroscopic spoiled gradient echo (GRE) and a balanced steady-state free precession (SSFP) magnetic resonance imaging (MRI) sequence.
In all, 103 patients with hepatocellular carcinomas (HCC) (41) or liver metastases (67) were treated using MR-guided radiofrequency ablation in a wide-bore 1.5 T scanner. A multislice real-time spoiled GRE sequence allowing for a T1 weighting (T1W) and a balanced SSFP sequence allowing for a T2/T1W contrast were used for MR guidance. The contrast-to-noise-ratio (CNR) of the lesions was calculated and lesion conspicuity was assessed retrospectively (easily detectable / difficult to detect / not detectable).
HCC was easily detectable in 33/52% (GRE/SSFP), difficult to detect in 30/18%, and not detectable in 37/30% of the cases. Mean CNR varied widely (9.1 for GRE vs. 16.4 for SSFP). Liver metastases were easily detectable in 58/41% (GRE/SSFP), difficult to detect in 14/21%, and not detectable in 28/38% of the cases. Mean CNR for liver metastases was 11.5 (GRE) vs. 12.7 (SSFP). Twenty percent of all lesions could not be detected with either of the MR fluoroscopy sequences.
MR fluoroscopy using GRE and SSFP contrast enabled real-time detectability of 80% of the liver lesions.
回顾性评估在透视扰相梯度回波(GRE)和平衡稳态自由进动(SSFP)磁共振成像(MRI)序列中肝脏病变的可视性。
总共103例肝细胞癌(HCC)(41例)或肝转移瘤(67例)患者在宽孔径1.5T扫描仪中接受了磁共振引导下的射频消融治疗。采用允许T1加权(T1W)的多层实时扰相GRE序列和允许T2/T1W对比的平衡SSFP序列进行磁共振引导。计算病变的对比噪声比(CNR),并回顾性评估病变的可视性(易于检测/难以检测/不可检测)。
HCC在33/52%(GRE/SSFP)的病例中易于检测,在30/18%的病例中难以检测,在37/30%的病例中不可检测。平均CNR差异很大(GRE为9.1,SSFP为16.4)。肝转移瘤在58/41%(GRE/SSFP)的病例中易于检测,在14/21%的病例中难以检测,在28/38%的病例中不可检测。肝转移瘤的平均CNR为11.5(GRE)对12.7(SSFP)。所有病变中有20%无法通过任何一种磁共振透视序列检测到。
使用GRE和SSFP对比的磁共振透视能够实时检测80%的肝脏病变。